# ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily Practice

> **NCT04349449** · — · WITHDRAWN · sponsor: **Takeda**

## Conditions studied

- Crohn Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04349449
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-09-30
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Business Decision (no enrollment)
- **Last updated:** 2020-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04349449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04349449, "ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily Practice". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04349449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*